KARA MORGAN: Open Payments
NPI 1720555683 · LOCKWOOD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,254 in 128 payments from 28 companies in 2025. Trend: 2023 $2,584 · 2024 $2,673 · 2025 $2,254
Food & beverage: $2,254
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 23 | $492 |
| ABBVIE INC. | 27 | $320 |
| Abbott Laboratories | 9 | $211 |
| Lilly USA, LLC | 12 | $177 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $123 |
| Novo Nordisk Inc | 6 | $99 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $80 |
| PFIZER INC. | 3 | $57 |
| Astellas Pharma US Inc | 2 | $53 |
Products named: BREZTRI, FREESTYLE LIBRE, VRAYLAR, MOUNJARO, TRINTELLIX, REXULTI, JARDIANCE, Ozempic.
Industry payments across MO — which companies pay providers there.
